Adam E Singer1,2, Joy R Goebel3, Yan S Kim4, Sydney M Dy5, Sangeeta C Ahluwalia2, Megan Clifford2, Elizabeth Dzeng6, Claire E O'Hanlon2,7, Aneesa Motala2, Anne M Walling1,2,8, Jaime Goldberg9, Daniella Meeker10, Claudia Ochotorena11, Roberta Shanman2, Mike Cui12, Karl A Lorenz2,13. 1. 1 David Geffen School of Medicine, University of California at Los Angeles , Los Angeles, California. 2. 2 RAND Corporation , Santa Monica, California. 3. 3 School of Nursing, California State University , Long Beach, Long Beach, California. 4. 4 Division of Research, Kaiser Permanente Northern California , Oakland, California. 5. 5 Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health , Baltimore, Maryland. 6. 6 Division of Hospital Medicine, University of California at San Francisco , San Francisco, California. 7. 7 Pardee RAND Graduate School , RAND Corporation, Santa Monica, California. 8. 8 Veterans Affairs Greater Los Angeles Healthcare System , Los Angeles, California. 9. 9 Supportive Care Medicine, Cedars-Sinai Medical Center , Los Angeles, California. 10. 10 Department of Preventive Medicine, University of Southern California , Los Angeles, California. 11. 11 Cedars-Sinai Medical Center , Los Angeles, California. 12. 12 RAND Corporation , Pittsburgh, Pennsylvania. 13. 13 Stanford University School of Medicine , Stanford, California.
Abstract
IMPORTANCE: Evidence supports palliative care effectiveness. Given workforce constraints and the costs of new services, payers and providers need help to prioritize their investments. They need to know which patients to target, which personnel to hire, and which services best improve outcomes. OBJECTIVE: To inform how payers and providers should identify patients with "advanced illness" and the specific interventions they should implement, we reviewed the evidence to identify (1) individuals appropriate for palliative care and (2) elements of health service interventions (personnel involved, use of multidisciplinary teams, and settings of care) effective in achieving better outcomes for patients, caregivers, and the healthcare system. EVIDENCE REVIEW: Systematic searches of MEDLINE, EMBASE, PsycINFO, Web of Science, and Cochrane Database of Systematic Reviews databases (1/1/2001-1/8/2015). RESULTS: Randomized controlled trials (124) met inclusion criteria. The majority of studies in cancer (49%, 38 of 77 studies) demonstrated statistically significant patient or caregiver outcomes (e.g., p < 0.05), as did those in congestive heart failure (CHF) (62%, 13 of 21), chronic obstructive pulmonary disease (COPD; 58%, 11 of 19), and dementia (60%, 15 of 25). Most prognostic criteria used clinicians' judgment (73%, 22 of 30). Most interventions included a nurse (70%, 69 of 98), and many were nurse-only (39%, 27 of 69). Social workers were well represented, and home-based approaches were common (56%, 70 of 124). Home interventions with visits were more effective than those without (64%, 28 of 44; vs. 46%, 12 of 26). Interventions improved communication and care planning (70%, 12 of 18), psychosocial health (36%, 12 of 33, for depressive symptoms; 41%, 9 of 22, for anxiety), and patient (40%, 8 of 20) and caregiver experiences (63%, 5 of 8). Many interventions reduced hospital use (65%, 11 of 17), but most other economic outcomes, including costs, were poorly characterized. Palliative care teams did not reliably lower healthcare costs (20%, 2 of 10). CONCLUSIONS: Palliative care improves cancer, CHF, COPD, and dementia outcomes. Effective models include nurses, social workers, and home-based components, and a focus on communication, psychosocial support, and the patient or caregiver experience. High-quality research on intervention costs and cost outcomes in palliative care is limited.
IMPORTANCE: Evidence supports palliative care effectiveness. Given workforce constraints and the costs of new services, payers and providers need help to prioritize their investments. They need to know which patients to target, which personnel to hire, and which services best improve outcomes. OBJECTIVE: To inform how payers and providers should identify patients with "advanced illness" and the specific interventions they should implement, we reviewed the evidence to identify (1) individuals appropriate for palliative care and (2) elements of health service interventions (personnel involved, use of multidisciplinary teams, and settings of care) effective in achieving better outcomes for patients, caregivers, and the healthcare system. EVIDENCE REVIEW: Systematic searches of MEDLINE, EMBASE, PsycINFO, Web of Science, and Cochrane Database of Systematic Reviews databases (1/1/2001-1/8/2015). RESULTS: Randomized controlled trials (124) met inclusion criteria. The majority of studies in cancer (49%, 38 of 77 studies) demonstrated statistically significant patient or caregiver outcomes (e.g., p < 0.05), as did those in congestive heart failure (CHF) (62%, 13 of 21), chronic obstructive pulmonary disease (COPD; 58%, 11 of 19), and dementia (60%, 15 of 25). Most prognostic criteria used clinicians' judgment (73%, 22 of 30). Most interventions included a nurse (70%, 69 of 98), and many were nurse-only (39%, 27 of 69). Social workers were well represented, and home-based approaches were common (56%, 70 of 124). Home interventions with visits were more effective than those without (64%, 28 of 44; vs. 46%, 12 of 26). Interventions improved communication and care planning (70%, 12 of 18), psychosocial health (36%, 12 of 33, for depressive symptoms; 41%, 9 of 22, for anxiety), and patient (40%, 8 of 20) and caregiver experiences (63%, 5 of 8). Many interventions reduced hospital use (65%, 11 of 17), but most other economic outcomes, including costs, were poorly characterized. Palliative care teams did not reliably lower healthcare costs (20%, 2 of 10). CONCLUSIONS: Palliative care improves cancer, CHF, COPD, and dementia outcomes. Effective models include nurses, social workers, and home-based components, and a focus on communication, psychosocial support, and the patient or caregiver experience. High-quality research on intervention costs and cost outcomes in palliative care is limited.
Authors: Angelo E Volandes; Laurie Anne Ferguson; Aretha D Davis; Nathan C Hull; Michael J Green; Yuchiao Chang; Kristy Deep; Michael K Paasche-Orlow Journal: J Palliat Med Date: 2011-01-21 Impact factor: 2.947
Authors: Karen L Syrjala; Janet R Abrams; Nayak L Polissar; Jennifer Hansberry; Jeanne Robison; Stuart DuPen; Mark Stillman; Marvin Fredrickson; Saul Rivkin; Eric Feldman; Julie Gralow; John W Rieke; Robert J Raish; Douglas J Lee; Charles S Cleeland; Anna DuPen Journal: Pain Date: 2008-01-08 Impact factor: 6.961
Authors: Nancy Wells; Joseph T Hepworth; Barbara A Murphy; Debra Wujcik; Rolanda Johnson Journal: J Pain Symptom Manage Date: 2003-04 Impact factor: 3.612
Authors: Glenn Gade; Ingrid Venohr; Douglas Conner; Kathleen McGrady; Jeffrey Beane; Robert H Richardson; Marilyn P Williams; Marcia Liberson; Mark Blum; Richard Della Penna Journal: J Palliat Med Date: 2008-03 Impact factor: 2.947
Authors: Galina Velikova; Laura Booth; Adam B Smith; Paul M Brown; Pamela Lynch; Julia M Brown; Peter J Selby Journal: J Clin Oncol Date: 2004-02-15 Impact factor: 44.544
Authors: Rhonda F Brown; Phyllis N Butow; Merin Anne Sharrock; Michael Henman; Fran Boyle; David Goldstein; Martin H N Tattersall Journal: Health Expect Date: 2004-12 Impact factor: 3.377
Authors: Ross E O'Hara; Jay G Hull; Kathleen D Lyons; Marie Bakitas; Mark T Hegel; Zhongze Li; Tim A Ahles Journal: Palliat Support Care Date: 2010-09-28
Authors: Michelle A Mollica; Ashley Wilder Smith; Emily Tonorezos; Kathleen Castro; Kelly K Filipski; Jennifer Guida; Frank Perna; Paige Green; Paul B Jacobsen; Angela Mariotto; Gina Tesauro; Lisa Gallicchio Journal: J Natl Cancer Inst Date: 2022-04-11 Impact factor: 13.506
Authors: Victor Dong; Maxime Gosselin; Nishita Jagarlamudi; Beverley Kok; Mark G Swain; Jasmohan S Bajaj; Juan G Abraldes; Vladimir Marquez; R Todd Stravitz; Aldo J Montano-Loza; Manuela Merli; Phil Wong; Amanda Brisebois; Puneeta Tandon; Julia Wendon; Scott L Nyberg; François M Carrier; Michael R Lucey; Florence Wong; Jordan J Feld; Constantine J Karvellas; Christopher F Rose; Julien Bissonnette Journal: Can Liver J Date: 2019-12-10
Authors: Anica Pless Kaiser; Kelly O'Malley; Jennifer Moye; Anna G Etchin; Lynn Korsun; Rachel Weiskittle; Hannah Bashian; Katherine Kemp; Zachary S Sager Journal: Prog Palliat Care Date: 2021-10-03
Authors: Kieran L Quinn; Mohammed Shurrab; Kevin Gitau; Dio Kavalieratos; Sarina R Isenberg; Nathan M Stall; Therese A Stukel; Russell Goldman; Daphne Horn; Peter Cram; Allan S Detsky; Chaim M Bell Journal: JAMA Date: 2020-10-13 Impact factor: 56.272
Authors: F Amos Bailey; Beverly R Williams; Patricia S Goode; Richard E Kennedy; David T Redden; Elizabeth Kvale; Marie Bakitas; J Nicholas Dionne-Odom; Kathryn L Burgio Journal: J Gen Intern Med Date: 2021-02-05 Impact factor: 6.473